Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Blood Advances|January 16, 2026
Improved survival and healthcare utilization with CAR-T vs historical care in relapsed-refractory large B-cell lymphomaTiana Kordbacheh, Kelvin Kw Chan, Michael Crump, et al.
Blood Neoplasia|October 28, 2025
Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapyChathuri Abeyakoon, Sita Bhella, Katrina Hueniken, et al.
Blood|July 14, 2019
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphomaCiara L Freeman, Robert Kridel, Alden A Moccia, et al.
Blood|November 11, 2017
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapyAnja Mottok, Vindi Jurinovic, Pedro Farinha, et al.
Blood Neoplasia|June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)Sarit Assouline, Anca Prica, Diego Villa, et al.
Leukemia|August 8, 2024
GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphomaMichael Y He, Kit I Tong, Ting Liu, et al.
Nature Communications|February 14, 2026
Blood-based epigenetic instability linked to human aging and diseaseSalman Basrai, Ido Nofech-Mozes, Rajesh Detroja, et al.
British Journal of Haematology|June 9, 2020
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphomaLourdes Calvente, Rosemarie Tremblay-LeMay, Wei Xu, et al.
Blood|February 3, 2016
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCLKerry J Savage, Graham W Slack, Anja Mottok, et al.
NPJ Precision Oncology|June 3, 2026
Detection and classification of lymphoma from cell-free methylome dataVictoria B Shelton, Mohamed Alias, Ting Liu, et al.
Pageof 10